Insulet Announces Omnipod Discover Now Available in U.S.

Web-based data platform turns Omnipod 5 data into clear, personalized insights for users, caregivers, and healthcare professionalsACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the ...
BIOENGINEER

AI Ensemble Predicts Blood Glucose in Type 1 Diabetes with Minimal Data Cleanup

Researchers at Fayoum University show that a simple averaged ensemble of machine learning models, evaluated on the OhioT1DM ...

Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th

SAN DIEGO, CA / ACCESS Newswire / October 7, 2026 / ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its ...
Vietnam Investment Review

SiBionics showcases automated insulin delivery technologies at EASD 2026

Medical technology developer SiBionics presented continuous glucose monitoring systems and automated insulin delivery solutions at the European Association for the Study of Diabetes 2026 conference.
FT Markets

Responding more frequently to MiniMed Smart MDI alerts linked to better glucose outcomes for people with diabetes

"These findings show a clear association between responding to Smart MDI alerts and better glucose outcomes. For people on multiple daily injections, that can mean more time in range with less ...
AD HOC NEWS

SMART02-Daten: Bei Bolusgaben ab 10 Einheiten öfter Sensorstörungen

SMART02-Daten zeigen meist seltene, kurzzeitige Sensorstörungen; weitere Studien sollen Leistung und Sicherheit des noch ...

SIBIONICS et PharmaSens explorent de nouvelles perspectives pour l'administration automatisée d'insuline lors du congrès de l'EASD 2026

Lors du congrès 2026 de l'Association européenne pour l'étude du diabète (EASD), SiBionics a présenté « See More, Act Earlier » (Voir plus : agir plus tôt), qui établit un lien entre la surveillance c ...

SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026

At the European Association for the Study of Diabetes (EASD) 2026, SiBionics presented 'See More, Act Earlier,' connecting continuous sensing with future diabetes care. Three exhibition chapters ...
clinicaltrialvanguard

Niia Signature Patch Shows 20-Minute Glucose Signal Recovery After Insulin Bolus

Niia Signature Patch achieves 20-minute glucose signal recovery after insulin bolus, addressing a key challenge in all-in-one ...
Medscape

Diabète de type 1 et boucle fermée : une révolution non exempte de contraintes

Dans la prise en charge du diabète de type 1, l’utilisation de la pompe à insuline en boucle fermée nécessite encore ...

Tandem Diabetes Care, Inc. annonce que le système d’administration automatisée d’insuline Tandem Mobi est désormais disponible sur 12 marchés internationaux

Tandem Diabetes Care, Inc. a annoncé que Tandem Mobi, le plus petit système durable d’administration automatisée d’insuline au monde destiné aux personnes diabétiques, est ...

TANDEM DIABETES CARE INC

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery system ...